Found 53 matching trials
Study to Evaluate the Mass Babance and Biotransformation of [14C]SHR6390 in Healthy Adult Male Volunteers PHASE1 Study to Evaluate the mass balance and biotransformation of single dose \[1...
Show More Location
First affiliated hospital,Soochow University
Learn More & Join Trial
Efficacy and Safety of Dalpiciclib in Hormone Receptor-positive Advanced Breast Cancer N/A This study is a multi-center, observational, real-world study. We planned t...
Show More Location
The Fourth hospital of Hebei University
Learn More & Join Trial
Molecularly Targeted Umbrella Study in Luminal Advanced Breast Cancer PHASE2 This study is a prospective, single-center, open-label, umbrella-shaped pha...
Show More Location
Cancer Hospital Affiliated to Fudan University
Learn More & Join Trial
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy PHASE2 The purpose of this study is to establish a prospective, single-center plat...
Show More Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Learn More & Join Trial
A Phase I Clinical Study on SHR6390 in Healthy Chinese Volunteers PHASE1 This study was to evaluate the pharmacokinetics and safety of SHR6390 at do...
Show More Location
Phase I Clinical Research Center
Learn More & Join Trial
An Exploratory Clinical Study of SHR6390 and SHR1020 in the Treatment of Esophageal Squamous Cell Carcinoma After Progression on PD-1 Antibody PHASE2 This study is being conducted to explore the efficacy of SHR-6390 and SHR-1...
Show More Location
Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
A Drug-drug Interaction Study of SHR6390 on Healthy Chinese Volunteers PHASE1 The study is a single-center, open, single-dose, self-controlled clinical t...
Show More Location
Xuanwu Hospital Beijing, Capital Medical University
Learn More & Join Trial
Study to Evaluate the Efficacy and Safety of SHR6390 Combined With Pyrotinib in HER2+ Advanced Breast Cancer PHASE2 The main purpose of this study was to observe the efficacy and safety of tr...
Show More Location
Henan Cancer Hospital
Learn More & Join Trial
A Phase 1 Study of HRS8807 Monotherapy and in Combination With SHR6390 in Subjects With ER-Positive, HER2-Negative Metastatic or Locally Advanced Breast Cancer PHASE1 The study is to assess safety and tolerability of HRS8807 monotherapy and i...
Show More Status
Active Not Recruiting
Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
A Clinical Trial of Breast Cancer Neo-adjuvant Therapy Based on Molecular Pathway in FUSCC PHASE1 This is a Phase Ib/II, prospective , open-label, single center, Bayesian ad...
Show More Learn More & Join Trial